Blog

Many lots of the drug Valsartan were recalled last year due to the contamination of n-nitrosodimethylamine (NDMA), a known animal carcinogen and a probable human carcinogen. More recently, a number of manufacturers recalled their Zantac and ranitidine products due to the belief that the drugs can naturally produce high levels of NDMA as a byproduct of the digestion…

If you received a letter warning about a contaminated heater-cooler unit used in your open-heart surgery, you may be at risk of contracting a nontuberculous mycobacteria (NTM) infection and should contact your doctor immediately. Why Did I Receive A Warning Letter After My Open Heart Surgery? On June 1, 2016, the Food and Drug Administration (FDA) advised…

Johnson & Johnson announced today it was discontinuing sales of its talc-based baby powder products in the United States and Canada amid a firestorm of lawsuits claiming its signature product contains asbestos. The announcement comes just weeks after US District Judge Freda Wolfson ruled to allow testimony from plaintiffs’ experts in the New Jersey-based Multidistrict Litigation. Thousands of claimants…

On May 8, 2020, Judge Robin L. Rosenberg of the US District Court for the Southern District of Florida appointed Goldenberg Lauricella Partner Marlene Goldenberg to the Plaintiffs’ Steering Committee as part of the leadership structure for the Zantac Multidistrict Litigation (MDL). Marlene is currently serving on the Plaintiffs’ Executive Committee for the Valsartan, Losartan, and Irbesartan MDL in the…

On April 1, 2020, The Food and Drug Administration (FDA) recommended the universal recall of all Zantac and ranitidine products from the U.S. market. The Zantac recall comes after various third party tests have found that unsafe levels of the probable human carcinogen NDMA can be produced in Zantac and ranitidine products as they are stored…

New testing from a California pharmacy has found elevated levels of the probable human carcinogen NDMA in Zantac when the drug is exposed to heat. As a result of its troubling findings, Emery Pharma has filed a Citizen Petition with the Food and Drug Administration (FDA) requesting the agency pull all products containing ranitidine, Zantac’s active ingredient, from…